The remarks come as U.S. health insurers balk at the extreme cost of Wegovy and other obesity drugs and drop them from their plans.
Source：https://www.cnbc.com/2023/11/02/wegovy-insured-patients-25-dollars-month.html
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
ADVERTISEMENT